Most ceramide subtype levels increased in obesity compared to normal-weight individuals, but the levels of serum Cer d18:0/18:0 and Cer d18:1/16:0 decreased in obesity. Here, CBLN1 is linked to obesity due to melanocortin 4 receptor deficiency.